NASDAQ: GNPX       Genprex Inc
Last Price Today's Change   Day's Range   Trading Volume
4.105   -0.575 (12.29%)  3.80 - 4.69  3,625,700


Avg Volume (4 weeks):13,619,957
4 Weeks Range:1.17 - 7.03
4 Weeks Price Volatility (%):
52 Weeks Range:0.23 - 7.03
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Genprex Inc is a US-based clinical stage gene therapy company. It is engaged in developing a new approach to treating cancer, based upon its novel proprietary technology platform, including initial product candidate, Oncoprex immunogene therapy. The company's lead product candidate is Oncoprex, which has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis in cancer cells, and modulates the immune response against cancer cells. Genprex is conducting preclinical research for developing Oncoprex to be administered with immunotherapies in non-small cell lung cancer as well as into other tumor suppressor genes.

  Be the first to like this.


5255  3112  425  130 

Top 10 Active Counters
 SPY 296.26-1.25 
 IBIO 2.45+1.585 
 CHK 0.275+0.015 
 EEM 40.52-0.15 
 XLF 26.59-0.74 
 BAC 28.50-0.63 
 GDX 26.22-1.93 
 GE 10.88+0.49 
 QQQ 205.80+1.90 
 VXX 22.81+0.81 
Partners & Brokers